Sponsors

Certificates of Confidentiality protect participant privacy by preventing disclosed sensitive information during research.

Coercion and undue influence in research can be complicated. Understand what these terms mean and how to appropriately protect against them.

Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."

On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.

Daniel Eisenman answers questions from his latest webinar Study Startup Success for the New Generation of Genetically Engineered Vaccines.

In investigator-initiated trials, an investigator takes on the clinical study as both the sponsor and investigator. Learn more about IITs impact on the clinical research industry.

New California regulations apply to companies who have information about CA residents regardless of where the company is located. Read more:

How has the COVID-19 pandemic changed oncology research--and research in general? Read more for the follow-up blog to our recent symposium:

COVID-19 complicates traditional models of community consultation. How should sites conducting planned emergency research approach community consultation?

Innovations in oncology have sparked advancements in the clinical trial industry and empowered COVID-19 research. Read more:

Gain a better understanding of clinical trial budget negotiations to reduce delays and study startup times.

Learn tips for developing and negotiating a clinical trial budget according to Medicare’s rules and regulations for device and drug clinical trials.